CHCHD3 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.858000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.300200E-01
Normal-vs-Stage2
4.459000E-01
Normal-vs-Stage3
5.938600E-01
Normal-vs-Stage4
9.458600E-01
Stage1-vs-Stage2
6.884400E-01
Stage1-vs-Stage3
3.113800E-01
Stage1-vs-Stage4
6.783600E-01
Stage2-vs-Stage3
1.403570E-01
Stage2-vs-Stage4
4.259200E-01
Stage3-vs-Stage4
5.738800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.791200E-01
Normal-vs-AfricanAmerican
2.287200E-01
Normal-vs-Asian
8.005400E-01
Caucasian-vs-AfricanAmerican
2.358400E-01
Caucasian-vs-Asian
5.346600E-01
AfricanAmerican-vs-Asian
3.006400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.801200E-01
Normal-vs-Female
4.985800E-01
Male-vs-Female
7.085800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.472200E-01
Normal-vs-Age(41-60Yrs)
2.471800E-01
Normal-vs-Age(61-80Yrs)
6.510600E-01
Normal-vs-Age(81-100Yrs)
2.814400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.219200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.984600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.842800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.913630E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
6.488600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.014600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
6.926400E-01
Normal-vs-Daily Drinker
5.457200E-01
Normal-vs-Weekly Drinker
5.742000E-01
Normal-vs-Occasional Drinker
4.800200E-01
Normal-vs-Social Drinker
3.145800E-01
Non Drinker-vs-Daily Drinker
7.168800E-01
Non Drinker-vs-Weekly Drinker
6.107200E-01
Non Drinker-vs-Occasional Drinker
6.825200E-01
Non Drinker-vs-Social Drinker
2.101000E-01
Daily Drinker-vs-Weekly Drinker
8.252200E-01
Daily Drinker-vs-Occasional Drinker
9.553400E-01
Daily Drinker-vs-Social Drinker
3.443200E-01
Weekly Drinker-vs-Occasional Drinker
8.601600E-01
Weekly Drinker-vs-Social Drinker
5.824600E-01
Occasional Drinker-vs-Social Drinker
3.654600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
8.719000E-01
Normal-vs-Grade 2
9.596000E-01
Normal-vs-Grade 3
9.610400E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.332500E-02
Grade 1-vs-Grade 3
6.748100E-02
Grade 1-vs-Grade 4
8.719000E-01
Grade 2-vs-Grade 3
9.673200E-01
Grade 2-vs-Grade 4
9.596000E-01
Grade 3-vs-Grade 4
9.610400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.281400E-01
Normal-vs-NonDiabetic
4.829200E-01
Diabetic-vs-NonDiabetic
7.996200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.051600E-01
Normal-vs-NoPancreatitis
5.181000E-01
Pancreatitis-vs-NoPancreatitis
1.029200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.959200E-01
Normal-vs-N1
4.475000E-01
N0-vs-N1
4.203000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.610400E-01
Normal-vs-TP53-NonMutant
7.035800E-01
TP53-Mutant-vs-TP53-NonMutant
1.899500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
